These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28447336)

  • 1. Review of recent molecular landscape knowledge of gastric cancer.
    Shimizu D; Kanda M; Kodera Y
    Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the molecular diagnostics of gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.
    Sawaki K; Kanda M; Kodera Y
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
    Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
    Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as promising biomarkers for gastric cancer.
    Wang F; Sun GP; Zou YF; Hao JQ; Zhong F; Ren WJ
    Cancer Biomark; 2012; 11(6):259-67. PubMed ID: 23248184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenetic mechanisms in gastric cancer.
    Shi J; Qu YP; Hou P
    World J Gastroenterol; 2014 Oct; 20(38):13804-19. PubMed ID: 25320518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
    Mu YP; Sun WJ; Lu CW; Su XL
    Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in gastric cancer.
    Ishiguro H; Kimura M; Takeyama H
    World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer.
    Sasahara M; Kanda M; Kodera Y
    Histol Histopathol; 2021 Aug; 36(8):817-832. PubMed ID: 33719028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
    Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
    World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-488 acts as a tumor suppressor gene in gastric cancer.
    Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
    Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
    Beeharry MK; Liu WT; Yan M; Zhu ZG
    World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
    Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
    Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in gastric cancer early diagnosis.
    Necula L; Matei L; Dragu D; Neagu AI; Mambet C; Nedeianu S; Bleotu C; Diaconu CC; Chivu-Economescu M
    World J Gastroenterol; 2019 May; 25(17):2029-2044. PubMed ID: 31114131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
    Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
    J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer.
    da Silva Oliveira KC; Thomaz Araújo TM; Albuquerque CI; Barata GA; Gigek CO; Leal MF; Wisnieski F; Rodrigues Mello Junior FA; Khayat AS; de Assumpção PP; Rodriguez Burbano RM; Smith MC; Calcagno DQ
    World J Gastroenterol; 2016 Sep; 22(35):7951-62. PubMed ID: 27672290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.